• Cytodyn request FDA EUA for M/M population due
Post# of 145410
• NEWS2 statistically significant (secondary endpoint) 2.5x better than placebo
• 70% SAE, AEs from study in placebo arm
• P3 study if no EUA from any country (~ 75-85 patients) due to NEWS2 score being already achieved and safety already established
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)